Headache recurrence with sumatriptan fast disintegrating tablets: results from two double-blind, placebo-controlled trials

被引：0
|
作者：
Dahlof, C
Taylor, FR
Mulleners, W
Adelman, J
Webster, C
Few, C
机构：
[1] Gothenburg Migraine Clin, Gothenburg, Sweden
[2] Pk Nicollet Hlth Serv, Minneapolis, MN USA
[3] Canisius Wilhelmina Hosp, Nijmegen, Netherlands
[4] Headache Wellness Ctr, Greensboro, NC USA
[5] GlaxoSmithKline Inc, Res Triangle Pk, NC USA
来源：
CEPHALALGIA | 2005年 / 25卷 / 10期
关键词：
sumatriptan; fast disintegrating; migraine; recurrence;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：927 / 927
页数：1
相关论文
共 50 条
  • [21] Topiramate in migraine prevention: A double-blind, placebo-controlled study
    Storey, JR
    Calder, CS
    Hart, DE
    Potter, DL
    HEADACHE, 2001, 41 (10): : 968 - 975
  • [22] Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
    Dodick, David W.
    Goadsby, Peter J.
    Lucas, Christian
    Jensen, Rigmor
    Bardos, Jennifer N.
    Martinez, James M.
    Zhou, Chunmei
    Aurora, Sheena K.
    Yang, Jyun Yan
    Conley, Robert R.
    Oakes, Tina
    CEPHALALGIA, 2020, 40 (09) : 935 - 948
  • [23] The effect of vitamin D on recurrence of uterine fibroids: A randomized, double-blind, placebo-controlled pilot study
    Vahdat, Mansoureh
    Allahqoli, Leila
    Mirzaei, Hossein
    Giovannucci, Edward
    Salehiniya, Hamid
    Mansouri, Ghazal
    Alkatout, Ibrahim
    COMPLEMENTARY THERAPIES IN CLINICAL PRACTICE, 2022, 46
  • [24] DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study
    Lipton, Richard B.
    Munjal, Sagar
    Brand-Schieber, Elimor
    Rapoport, Alan M.
    HEADACHE, 2018, 58 (05): : 676 - 687
  • [25] Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks. A randomized, double-blind, placebo-controlled study
    Tfelt-Hansen, P
    Bach, F
    Daugaard, D
    Tsiropoulos, I
    Riddersholm, B
    CEPHALALGIA, 2005, 25 (10) : 932 - 932
  • [26] Behavioral research and the double-blind placebo-controlled methodology: Challenges in applying the biomedical standard to behavioral headache research
    Rains, JC
    Penzien, DB
    HEADACHE, 2005, 45 (05): : 479 - 486
  • [27] Oral magnesium oxide prophylaxis of frequent migrainous headache in children: A randomized, double-blind, placebo-controlled trial
    Wang, F
    Van den Eeden, SK
    Ackerson, LM
    Salk, SE
    Reince, RH
    Elin, RJ
    HEADACHE, 2003, 43 (06): : 601 - 610
  • [28] STEROIDS FOR MIGRAINE HEADACHES: A RANDOMIZED DOUBLE-BLIND, TWO-ARMED, PLACEBO-CONTROLLED TRIAL
    Fiesseler, Frederick W.
    Shih, Richard
    Szucs, Paul
    Silverman, Michael E.
    Eskin, Barnet
    Clement, Martin
    Saxena, Rachna
    Allegra, John
    Riggs, Renee L.
    Majlesi, Nima
    JOURNAL OF EMERGENCY MEDICINE, 2011, 40 (04) : 463 - 467
  • [29] Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial
    Lakshmi, C. V. S.
    Singhi, Pratibha
    Malhi, Prahbhjot
    Ray, MLinni
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (07) : 829 - 835
  • [30] Double-blind randomized placebo-controlled study of homoeopathic prophylaxis of migraine
    Whitmarsh, TE
    ColestonShields, DM
    Steiner, TJ
    CEPHALALGIA, 1997, 17 (05) : 600 - 604
12345